Ultrasound Shows Promise in Parkinson’s Treatment
An ultrasound treatment showed promise in improving the physical symptoms of Parkinson’s disease in a clinical trial.
An ultrasound treatment showed promise in improving the physical symptoms of Parkinson’s disease in a clinical trial.
People with weight changes soon after being diagnosed with Parkinson’s disease may be more likely to have changes in their thinking skills than people who maintain their weight, according to a recent study.
New coding and coverage by commercial and government payors makes it easier for physicians to prescribe and patients to afford Cala Health’s clinically proven treatment for essential tremor, Cala Trio therapy, the company notes in a media release.
The Michael J. Fox Foundation for Parkinson’s Research has awarded a $670,000 grant to Yesse Technologies Inc to advance its nose-on-chip platform to detect the characteristic smell linked to Parkinson’s disease (PD).
Read MoreThe Parkinson’s Foundation announces the results of a survey measuring how people with Parkinson’s disease (PD) are coping during the COVID-19 pandemic. Complete results are available in npj Parkinson’s Disease.
Read MorePatients who have been diagnosed with Parkinson’s disease might actually have NIID instead, according to a joint study by the National Neuroscience Institute (NNI) and Singapore General Hospital (SGH) published in JAMA Neurology.
Read MoreCala Health Inc reports data demonstrating the increasing prevalence of essential tremor (ET) from 2010 to 2018; a high rate of depression and anxiety in patients with ET; and the safety and efficacy of Cala Trio when used in a real-world setting to treat ET.
Read MoreThe US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Cala Trio for the treatment of action tremors in the hands of adults with Parkinson’s disease, Cala Health Inc reports in a news release.
Read MoreAlexandra Taratuski, PT, DPT, explains how to optimize your physical therapy treatment sessions and use exercise as a form of medication to overcome symptoms of Parkinson’s disease, in this feature for the Fall 2020 Rehab Management Product Guide.
Read MoreResearchers looking at the brainstems of children and young adults exposed lifelong to air pollution in Mexico City have discovered disturbing evidence of neurological harm. Their study is published in Environmental Research.
Read MoreSpinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective, according to researchers from the United States and Japan, in Bioelectronic Medicine.
Read MoreUniversity of Wisconsin-Madison researchers demonstrate a proof-of-concept stem cell treatment in a mouse model of Parkinson’s disease. They suggest that neurons derived from stem cells can integrate well into the correct regions of the brain, connect with native neurons and restore motor functions.
Read MoreRepresentatives from Cala Health Inc recently presented data demonstrating that Cala Trio therapy is safe and effective in improving tremors in patients with essential tremor (ET) when used at home, unsupervised, and under real-world conditions.
Read MoreThe American Parkinson Disease Association (APDA) reports the awarding of $1.4 million in grants to support Parkinson’s disease (PD) research for the 2020-2021 funding year.
Read MoreThe Parkinson’s Foundation announces expanded virtual programs to support the Parkinson’s disease (PD) community during the ongoing COVID-19 pandemic.
Read MoreThe Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces the re-launch of its Parkinson’s Podcast — a monthly conversation hosted by Larry Gifford and designed to help people with Parkinson’s disease (PD) and their care partners stay informed on the latest topics in research and care.
Read MoreThe 6th annual World Brain Day on July 22 is dedicated to raising awareness for Parkinson’s Disease, according to a news release.
Read MorePreliminary results from the PD GENEration: Mapping the Future of Parkinson’s Disease pilot study demonstrate the feasibility to conduct comprehensive genetic testing and genetic counseling for the larger Parkinson’s disease (PD) community, as well as the identification of rare genetic mutation carriers linked to PD.
Read More